192 related articles for article (PubMed ID: 15828218)
1. [Recent advances in PPARs research--basic and clinical aspects].
Kadowaki T
Nihon Rinsho; 2005 Apr; 63(4):539-48. PubMed ID: 15828218
[TBL] [Abstract][Full Text] [Related]
2. The selected pathophysiological aspects of PPARs activation.
Kieć-Wilk B; Dembińska-Kieć A; Olszanecka A; Bodzioch M; Kawecka-Jaszcz K
J Physiol Pharmacol; 2005 Jun; 56(2):149-62. PubMed ID: 15985699
[TBL] [Abstract][Full Text] [Related]
3. Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors.
Gervois P; Fruchart JC; Staels B
Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):145-56. PubMed ID: 17237841
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptors and atherosclerosis.
Soskić SS; Dobutović BD; Sudar EM; Obradović MM; Nikolić DM; Zarić BL; Stojanović SD; Stokić EJ; Mikhailidis DP; Isenović ER
Angiology; 2011 Oct; 62(7):523-34. PubMed ID: 21467121
[TBL] [Abstract][Full Text] [Related]
5. [PPAR and diabetes].
Terauchi Y; Kadowaki T
Nihon Rinsho; 2005 Apr; 63(4):623-9. PubMed ID: 15828230
[TBL] [Abstract][Full Text] [Related]
6. Be fit or be sick: peroxisome proliferator-activated receptors are down the road.
Desvergne B; Michalik L; Wahli W
Mol Endocrinol; 2004 Jun; 18(6):1321-32. PubMed ID: 15087471
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptors and inflammation.
Moraes LA; Piqueras L; Bishop-Bailey D
Pharmacol Ther; 2006 Jun; 110(3):371-85. PubMed ID: 16168490
[TBL] [Abstract][Full Text] [Related]
8. The metabolic syndrome: relationship between insulin sensitivity and the role of peroxisome proliferator-activated receptors (PPARs) in saccharide and lipid metabolism.
Yahia RB; Lichnovská R; Brychta T
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):237-41. PubMed ID: 16601762
[TBL] [Abstract][Full Text] [Related]
9. [The structures and functions of peroxisome proliferator-activated receptors (PPARs)].
Takahashi N; Goto T; Kusudo T; Moriyama T; Kawada T
Nihon Rinsho; 2005 Apr; 63(4):557-64. PubMed ID: 15828220
[TBL] [Abstract][Full Text] [Related]
10. PPARs and the kidney in metabolic syndrome.
Ruan X; Zheng F; Guan Y
Am J Physiol Renal Physiol; 2008 May; 294(5):F1032-47. PubMed ID: 18234957
[TBL] [Abstract][Full Text] [Related]
11. A nonthiazolidinedione peroxisome proliferator-activated receptor α/γ dual agonist CG301360 alleviates insulin resistance and lipid dysregulation in db/db mice.
Jeong HW; Lee JW; Kim WS; Choe SS; Shin HJ; Lee GY; Shin D; Lee JH; Choi EB; Lee HK; Yon GH; Cho B; Kim HR; Choi SH; Chung YS; Park SB; Chung H; Ro S; Kim JB
Mol Pharmacol; 2010 Nov; 78(5):877-85. PubMed ID: 20724462
[TBL] [Abstract][Full Text] [Related]
12. Evolution of peroxisome proliferator-activated receptor agonists.
Chang F; Jaber LA; Berlie HD; O'Connell MB
Ann Pharmacother; 2007 Jun; 41(6):973-83. PubMed ID: 17519293
[TBL] [Abstract][Full Text] [Related]
13. [PPARs-mediated intracellular signal transduction].
Fujii H
Nihon Rinsho; 2005 Apr; 63(4):565-71. PubMed ID: 15828221
[TBL] [Abstract][Full Text] [Related]
14. Obesity, peroxisome proliferator-activated receptor, and atherosclerosis in type 2 diabetes.
Blaschke F; Takata Y; Caglayan E; Law RE; Hsueh WA
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):28-40. PubMed ID: 16239592
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.
Marx N; Duez H; Fruchart JC; Staels B
Circ Res; 2004 May; 94(9):1168-78. PubMed ID: 15142970
[TBL] [Abstract][Full Text] [Related]
16. [PPARs: the role in glucose and lipid homeostasis, insulin resistance and atherosclerosis].
Hrebícek J
Cesk Fysiol; 2004; 53(1):4-16. PubMed ID: 15702884
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism.
Giaginis C; Tsantili-Kakoulidou A; Theocharis S
Fundam Clin Pharmacol; 2007 Jun; 21(3):231-44. PubMed ID: 17521292
[TBL] [Abstract][Full Text] [Related]
18. [PPARs and heart diseases].
Takano H; Komuro I
Nihon Rinsho; 2005 Apr; 63(4):659-64. PubMed ID: 15828234
[TBL] [Abstract][Full Text] [Related]
19. [PPARs target genes].
Takada I; Kato S
Nihon Rinsho; 2005 Apr; 63(4):573-7. PubMed ID: 15828222
[TBL] [Abstract][Full Text] [Related]
20. PPAR ligands: are they potential agents for cardiovascular disorders?
Balakumar P; Rose M; Singh M
Pharmacology; 2007; 80(1):1-10. PubMed ID: 17496434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
